PharmaRadar360
PharmaRadar360
Intelligence Layer
🇺🇸·5h agoIndustry

Bristol Myers Squibb and Pfizer to Make Eliquis® (apixaban) Available via Mark Cuban Cost Plus Drug Company

Publisher

B
Bristol-Myers Squibb News

USA

This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.

Read original

In-platform summary, original article off-platform

This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.

Source route

Continue on bristolmyers2016ir.q4web.com

Leave the platform to read the original full article on the publisher site.

Source: Bristol-Myers Squibb News

Scope: Industry

Open original article
Bristol Myers Squibb and Pfizer to Make Eliquis® (apixaban) Available via Mark Cuban Cost Plus Drug Company | PharmaRadar360